Concepedia

Farrukh T. Awan

FT

Statistics

Publications

99

Citations

7.6K

H-Index

43

Active since

2006

Affiliations

The Ohio State University(Current)

The University of Texas Southwestern Medical Center

Memorial Sloan Kettering Cancer Center

Fred Hutch Cancer Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Farrukh T. Awan is an author at The Ohio State University specializing in medicine, oncology, and chronic lymphocytic leukemia therapy.

ORCID

Publications per year

2006–2025

99

Publications

99

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 891 citations · Full text

, , +13

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia

Kami J. Maddocks, Amy S. Ruppert, Gerard Lozanski et al. · JAMA Oncology · 2015 · 576 citations · Full text

, , +16

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George et al. · New England Journal of Medicine · 2016 · 478 citations · Full text

, , +16

<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn et al. · Journal of Clinical Oncology · 2017 · 471 citations

, , +16

Ibrutinib treatment improves T cell number and function in CLL patients

Meixiao Long, Kyle A. Beckwith, Priscilla Do et al. · Journal of Clinical Investigation · 2017 · 377 citations · Full text

, , +17

1–5 of 99